Catalyst Wire Dossier Catalyst Wire Dossier

AAV1/SERCA2a gene transfer

AAV1/SERCA2a
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAV1/SERCA2a gene transfer, covering 2020-02-25 to 2020-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Investigation of the Safety and Feasibility of AAV1/SERCA2a Gene Transfer in Patients With Chronic Heart Failure [Phase 2]

See pricing